News
10,998 News Articles
Jan
17
2025
Enthea to Present at the 2025 Sequire Investor Summit in Puerto Rico | The Manila Times
... ketamine-assisted therapy and stellate ganglion block. These FDA-approved, clinician-supervised medicines have demonstrated extraordinary outcomes ...
Jan
17
2025
Lykos still plotting path to approval for rejected MDMA therapy after 'productive' FDA meeting
One of the biggest stories of last year was Lykos Therapeutics' failure to get its MDMA candidate over the finish line for post-traumatic stress ...
MDMA
Jan
17
2025
Self‐reported experiences and perspectives on using psychedelics to manage opioid use ...
Psychedelics are emerging as a possible alternative therapy for mental health and substance use disorders. This study aimed to gather insights on how ...
Psychedelics
Jan
17
2025
Magic Mushroom Can't Be Treated As A Mixture; Not A Scheduled Narcotic Or Psychotropic ...
... Psilocybin contained magic mushroom capsules, while travelling in a car. ... The High Court in view of the above facts, noted, “… it is clear that the ...
Psilocybin
Jan
17
2025
Minnesota task force recommends decriminalizing magic mushrooms - MSN
... psilocybin-containing mushrooms. Remove criminal penalties for the personal use and possession of psilocybin-containing mushrooms. Microsoft Start ...
Jan
17
2025
Neuroscientists have mapped what happens to your brain when you take shrooms—and it's ... - MSN
A new paper published in 'Nature' could have implications for using hallucinogenics to treat mental illnesses like depression and anxiety. Psilocybin ...
Jan
17
2025
NDPS Act| 'Magic Mushroom' Not A Scheduled Narcotic/Psychotropic Substance, Can't Be ...
It was also argued that the average psilocybin content in Psilocybe cubensis mushrooms is 1% per gram, and that even if the entire quantity of magic ...
Jan
16
2025
Updated harms assessment of ketamine: commissioning letter - GOV.UK
Following the ACMD's review in 2013, ketamine was moved from Class C to Class B under the Misuse of Drugs Act 1971 (“1971 Act”) in 2014, due to its ...
Jan
16
2025
Can ayahuasca change a man? The rise of trips against misunderstood masculinity
Psychedelic experiences, now in vogue among Silicon Valley's elite, could be key tools for deconstructing men. But users and experts warn that the ...
Jan
16
2025
Bipartisan bill allowing synthetic psilocybin in Colorado passes first test - KUNC
Psilocybin, the active compound in psychedelic mushrooms, was legalized by Colorado voters in 2022. But according to two of the bill's sponsors, Reps.
Jan
16
2025
Recreational ketamine use on the rise, researchers say | cbs8.com
A powerful psychedelic drug is gaining attention, and not just in medical circles. Recreational ketamine use has local researchers sounding the ...
Jan
16
2025
Recreational ketamine use on the rise, researchers say - YouTube
As recreational use of ketamine dramatically rose, researchers are sounding the alarm about its potential health risks.
Jan
16
2025
Sibannac Teams with TV Star William Henry to Launch Psychedelic Wellness Platform ... - Stock Titan
... psychedelics. The first podcast interview is scheduled for January 20th. The company is launching Starwalker Journeys, premium travel destinations ...
Jan
16
2025
Neuroscientists have mapped what happens to your brain when you take shrooms—and it's ... - MSN
Psilocybin, a hallucinogenic found in magic mushrooms, has the ... Psilocybin alters how rats balance risks and rewards, researchers find.
Psilocybin
Jan
16
2025
Lykos Therapeutics Reshuffles Board of Directors Following FDA Rejection of ...
In response to the CRL, MAPS announced its intentions to plan out a successful path towards safe, legal access to MDMA-assisted therapy, with ...
Jan
16
2025
Updated harms assessment of ketamine: commissioning letter - GOV.UK
The government commissions the Advisory Council on the Misuse of Drugs (ACMD) to conduct an updated harms assessment of ketamine.
Jan
15
2025
U of Md hopes to educate public and professionals about psychedelic therapies | WYPR
The use of psychedelic-assisted therapy to treat trauma and other ailments is on the rise. University of Maryland puts it front and center with an ...
Jan
15
2025
CB Therapeutics Breaks Ground on Sustainable Ergoline Biosynthesis Through Precision ...
While many recognize ergolines through their association with lysergic acid derivatives-including LSD ... Broad Application Potential: Beyond ...
LSD
Jan
15
2025
Colorado bipartisan trigger bill on synthetic psilocybin passes first hearing
This bill would remove that classification for synthesized psilocybin, if a compound does get approved by the FDA. Psilocybin, the active compound in ...
Jan
15
2025
Low-Dose Sublingual Ketamine for the Treatment of Raynaud's Phenomenon | Cureus
... Ketamine, an FDA-approved anesthetic since 1970, exhibits analgesic and vasodilatory properties that may enhance perfusion. This case report ...
Ketamine
Jan
15
2025
Rise in Ketamine Use Seen From 2015 to 2022 - MPR - eMPR.com
Depression was associated with increased odds of ketamine use in the 2015 to 2019 period (adjusted odds ratio, 1.80) but not in later years. From 2021 ...
Ketamine
Jan
15
2025
The Octopus's Psychadelic Trip: Dr. Gül Dölen on Psychedelics and the Brain | Being Patient
Neuroscientists are currently researching how psychedelic drugs like MDMA, LSD, psilocybin, ketamine, and ibogaine reveal how our brains work and, ...
Psychedelics
Jan
15
2025
Psychedelics may Aid the Spirit and Body - Atlanta Jewish Times
Rabbi Jay Michaelson believes the Jewish spiritual tradition may have had a psychedelic component. Could the kinea bosem, a substance that was a ...
Jan
15
2025
Lykos loses five board directors after FDA rejection - PharmaLive
Months after the FDA declined to approve its MDMA-assisted post-traumatic stress disorder therapy, the psychedelics-focused drugmaker announced on ...
Jan
15
2025
My Bad, You Got This: witnessing, therapist attitude and the synergy between psychedelics ...
The MAPS (Multidisciplinary Association for Psychedelic Studies) sponsored MDMA-assisted therapy protocol has had greater success in treating ...
Jan
15
2025
Lykos Loses Five Board Directors After FDA Rejection - BioSpace
Lykos Therapeutics is currently working out ways to fund an additional Phase III study for its MDMA-assisted PTSD therapy following an FDA setback ...
Jan
14
2025
OPINION: The evidence is clear: Nevada must move forward on psychedelic therapies
Our investigation revealed strong evidence supporting the therapeutic potential of naturally occurring psychedelics such as psilocybin, ...
Jan
14
2025
Recreational Ketamine Use Surging Among Young Adults - HealthDay
A new study finds a dramatic increase in the number of adults using ketamine for recreational purposes. Ketamine is a medical anesthetic that has ...
Ketamine
Jan
14
2025
Frameworks for Advancing Health Equity: Accessing Ketamine-Assisted Therapy
... mental health and address access barriers to evidence-based ketamine treatments.
Jan
14
2025
KETAMINE THERAPY IS GETTING GROOVIER (PART II) - Substack
Would this be like a concert, except with doctors running around with ketamine injections? Or would it be more like a psychedelic ceremony, except ...
Jan
14
2025
Psychedelic Drugs Market Projected to Reach $11.34 Billion by 2030 at a 15.1% CAGR
Thailand's psychedelic drugs market is witnessing a shift towards natural psychedelics like psilocybin mushrooms. Regulatory advancements, such as ...
Jan
13
2025
Upgrading ketamine to a class A drug won't stop the party | The Independent
The Home Office's tougher stance on ketamine will not affect its allure – it could even enhance it, writes drug expert Ian Hamilton.
Jan
13
2025
Psilocybin healing centers coming to Boulder as city council approves new rules
The rules stem from a 2022 Colorado ballot measure creating the Natural Medicine Health Act, which decriminalized psilocybin cultivation and personal ...
Jan
13
2025
'This dangerous substance was not intended for chronic use' | Bridport and Lyme Regis News
... ketamine. David Sidwick has expressed his support for the Home Office's decision to review the classification of the drug ketamine. The ...
Jan
13
2025
Optimi Health Reports First Patients Dosed in Landmark Natural Psilocybin Study in New Zealand
(CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of psychedelic pharmaceuticals specializing ...
Psilocybin
Jan
13
2025
Naropa University breaks ties with psychedelic studies, spawning independent healing center
The Boulder institution will shed its groundbreaking Center for Psychedelic Studies into the collaborative, independent Memoru Center for ...